Position history for NewEdge Advisors, LLC's holdings in Monopar Therapeutics Inc.
NewEdge Advisors, LLC holds 600 shares of MNPR (Monopar Therapeutics Inc.), worth $39,180 as of 2025-Q4. MNPR represents 0.0% of NewEdge Advisors, LLC's portfolio.
Current Value
$39,180
Current Shares
600
Total Value Change
+$37,137
Total Shares Change
-2,400
Other major holders of MNPR: JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P.
Unchanged |
| 600 |
0.0% |
| $39,180 |
| 0.0% |
| $65.07 |
0 |
| 2025-Q3 | Unchanged | 600 | 0.0% | $49,002 | 0.0% | $75.90 | 0 |
| 2025-Q2 | Unchanged | 600 | 0.0% | $21,468 | 0.0% | $33.60 | 0 |
| 2025-Q1 | Unchanged | 600 | 0.0% | $21,846 | 0.0% | $40.33 | 0 |
| 2024-Q4 | Unchanged | 600 | 0.0% | $13,200 | 0.0% | $23.85 | 0 |
| 2024-Q3 | Decreased | 600 | -80.0% | $4,044 | 0.0% | $6.77 | 0 |
| 2024-Q2 | Unchanged | 3,000 | 0.0% | $2,190 | 0.0% | $3.65 | 0 |
| 2024-Q1 | New | 3,000 | - | $2,043 | 0.0% | $3.40 | 17 |